Chandan Healthcare Peer Comparison
NSE: CHANDAN
₹211.50
As on 04-Sep-2026 15:32IST
Market cap
₹517 Cr
Revenue (TTM)
₹230 Cr
P/E Ratio
19.1
P/B Ratio
2.9
Div. Yield
0 %
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
517 | 39,493 | 32,095 | 31,470 | 15,412 |
Revenue (₹ Cr) |
230 | 4,683 | 4,213 | 2,891 | 857 |
Net Profit (₹ Cr) |
23.52 | 552.34 | 190.80 | 546.30 | 187.49 |
Net Margin (%) |
10.13 | 11.55 | 4.49 | 18.23 | 21.32 |
RoE (%) |
28.72 | 14.93 | 9.45 | 23.03 | 20.58 |
Price to Earnings |
19.11 | 71.01 | 157.10 | 58.07 | 82.20 |
Price-To-Book |
2.91 | 9.61 | 8.48 | 12.04 | 15.30 |
Income Statement (₹ Cr)
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Operating Revenue
|
230.12 | 3,692.35 | 3,035.10 | 2,461.40 | 681.39 |
|
Total Income
|
232.17 | 3,797.15 | 3,067.00 | 2,554.83 | 699.71 |
|
Total Expenditure
|
188.79 | 2,831.90 | 2,242.10 | 1,765.80 | 408.17 |
|
EBITDA
|
41.33 | 860.44 | 793.00 | 695.60 | 273.22 |
|
Depreciation
|
6.74 | 193.75 | 177.20 | 141.92 | 70.60 |
|
EBIT
|
34.59 | 666.69 | 615.80 | 553.67 | 202.62 |
|
Interest
|
4.58 | 74.35 | 100.40 | 22.31 | 26.74 |
|
Other Income
|
2.05 | 104.81 | 31.90 | 93.43 | 18.32 |
|
Exceptional Items
|
-- | -49.90 | 10.80 | -- | -1.03 |
|
Profit before Tax
|
32.06 | 647.26 | 558.10 | 624.80 | 193.16 |
|
Provision for Tax
|
8.55 | 165.94 | 143.30 | 132.55 | 49.37 |
|
Profit after Tax
|
23.52 | 481.32 | 414.80 | 492.25 | 143.79 |
Liabilities (₹ Cr)
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
122.60 | 3,386.41 | 2,137.80 | 2,172.72 | 799.14 |
|
Minority Interest
|
3.80 | 1.10 | 281.00 | 33.76 | -- |
|
Non-Current Liabilities
|
27.33 | 726.88 | 2,421.10 | 21.34 | 311.86 |
|
Current Liabilities
|
56.88 | 618.82 | 836.20 | 402.35 | 162.61 |
|
Total Liabilities
|
210.62 | 4,766.23 | 5,689.20 | 2,713.41 | 1,273.62 |
Assets (₹ Cr)
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
100.31 | 3,200.08 | 4,978.80 | 1,266.66 | 966.41 |
|
Current Assets
|
110.31 | 1,533.12 | 697.30 | 1,363.51 | 307.21 |
|
Total Assets
|
210.62 | 4,766.23 | 5,689.20 | 2,713.41 | 1,273.62 |
|
Total Debt*
|
48.16 | 327.88 | 1,910.90 | 0.00 | 0.00 |
|
Net Current Assets
|
53.43 | 914.31 | -138.90 | 961.16 | 144.59 |
|
Contingent Liabilities
|
17.40 | 88.77 | 83.80 | 10.59 | 0.13 |
Cashflow (₹ Cr)
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-29.05 | 623.76 | 581.80 | 568.89 | 224.47 |
|
Cash Flow from Investing Activities
|
-35.75 | -720.94 | -1,116.20 | -303.16 | -181.88 |
|
Cash from Financing Activities
|
67.11 | -97.23 | 543.10 | -334.03 | -52.05 |
|
Net Cash Inflow / Outflow
|
2.31 | -194.41 | 8.70 | -68.31 | -9.45 |
Ratios
Profitability Ratios
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
ROCE (%)
|
29.57 | 20.50 | 19.02 | 31.53 | 30.20 |
|
ROE (%)
|
28.72 | 15.31 | 20.92 | 25.15 | 19.99 |
|
ROA (%)
|
14.31 | 10.72 | 8.74 | 19.53 | 12.76 |
|
EBIT Margin (%)
|
18.85 | 26.14 | 27.18 | 32.06 | 42.79 |
|
Net Margin (%)
|
10.13 | 12.68 | 13.52 | 19.27 | 20.55 |
|
Cash Profit Margin (%)
|
13.15 | 18.28 | 19.51 | 25.76 | 31.46 |
Growth Ratios
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
30.31 | 12.74 | 21.49 | 10.54 | 24.39 |
|
EBIT Growth (%)
|
57.09 | 9.24 | 24.83 | 16.31 | 20.61 |
|
Net Profit Growth (%)
|
43.77 | 0.68 | 23.49 | 35.87 | 20.19 |
|
EPS Growth (%)
|
11.41 | 0.65 | 24.03 | 35.99 | 20.67 |
|
Book Value Growth (%)
|
197.86 | 16.71 | 16.93 | 17.68 | 19.36 |
Valuation Ratios
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Price / Earnings
|
19.96 | 66.85 | 66.51 | 21.26 | 71.86 |
|
Price / Book Value
|
3.61 | 9.50 | 11.96 | 9.79 | 13.20 |
|
Dividend Yield (%)
|
0.00 | 0.04 | 0.00 | 0.97 | 0.20 |
|
EV/EBITDA
|
11.17 | 32.52 | 33.22 | 25.19 | 35.28 |
|
Market Cap (₹ Cr)
|
442.59 | 32,181.74 | 25,571.93 | 20,714.85 | 10,333.01 |
Solvency Ratios
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.39 | 0.10 | 0.89 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.15 | -- | 0.06 | -- | -- |
|
Current Ratio
|
1.94 | 2.48 | 0.83 | 3.39 | 1.89 |
|
Quick Ratio
|
1.39 | 2.37 | 0.76 | 3.30 | 1.86 |
|
Interest Coverage
|
8.01 | 9.71 | 6.56 | 29.01 | 8.22 |
Operating Efficiency Ratios
| Chandan Healthcare | Global Health | Krishna Institute | Dr. Lal Pathlabs | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.29 | 7.90 | 13.03 | 3.58 | 2.17 |
|
Asset Turnover
|
1.40 | 0.82 | 0.64 | 0.98 | 0.60 |
|
Receivable days
|
59.72 | 25.07 | 41.48 | 12.27 | 8.30 |
|
Inventory Days
|
39.35 | 6.62 | 6.82 | 5.45 | 2.71 |
|
Payable days
|
89.69 | 79.17 | 135.60 | 134.04 | 142.28 |
|
Cash Conversion Cycle
|
9.38 | -47.48 | -87.31 | -116.32 | -131.27 |